soul trial oral semaglutide cardiovascular outcomes 2024 nejm results Editorial Fellow Harleen Marwah, MD, summarizes the trial. Visit NEJM.org for the full results. #ACC25 #Cardiology #ClinicalTrials #MedTok #NEJM soul trial oral semaglutide cardiovascular

What some people lose on a GLP-1 course compresses years of that process into a single treatment window

Dont hesitate to reach out to your healthcare team for personalized advice and guidance

Because retatrutide is unlicensed, it may only be used lawfully in the UK within an authorised clinical trial (as an Investigational Medicinal Product, or IMP) or under specific MHRA-regulated frameworks for unlicensed medicines

Breastfeeding Diet Guide: What Matters Most It can be hard to know what to eat after giving birth

Yes, both require prescription-only medical supervision in the UK

When Another App May Be Better Choose Medisafe or MyTherapy if your need is generic medication reminders unrelated to GLP-1 pill bottles, multi-medication schedules across unrelated drugs, or vitamin reminders